As of 2025-07-17, the Relative Valuation of Pulmonx Corp (LUNG) is (23.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.91 USD, the upside of Pulmonx Corp based on Relative Valuation is -921.1%.
The range of the Relative Valuation is (24.68) - (28.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.4x - 26.2x | 20.2x |
| Forward P/E multiples | 13.3x - 20.0x | 13.5x |
| Fair Price | (24.68) - (28.33) | (23.90) |
| Upside | -947.9% - -1073.7% | -921.1% |
| Date | P/E |
| 2025-07-16 | -2.05 |
| 2025-07-15 | -1.90 |
| 2025-07-14 | -1.89 |
| 2025-07-11 | -2.04 |
| 2025-07-10 | -1.87 |
| 2025-07-09 | -1.93 |
| 2025-07-08 | -1.93 |
| 2025-07-07 | -1.86 |
| 2025-07-03 | -1.96 |
| 2025-07-02 | -1.92 |
| 2025-07-01 | -1.90 |
| 2025-06-30 | -1.83 |
| 2025-06-27 | -1.83 |
| 2025-06-26 | -1.83 |
| 2025-06-25 | -1.85 |
| 2025-06-24 | -1.90 |
| 2025-06-23 | -1.81 |
| 2025-06-20 | -1.85 |
| 2025-06-18 | -1.94 |
| 2025-06-17 | -1.91 |
| 2025-06-16 | -2.10 |
| 2025-06-13 | -2.14 |
| 2025-06-12 | -2.21 |
| 2025-06-11 | -2.30 |
| 2025-06-10 | -2.40 |
| 2025-06-09 | -2.40 |
| 2025-06-06 | -2.24 |
| 2025-06-05 | -2.09 |
| 2025-06-04 | -2.17 |
| 2025-06-03 | -2.24 |
| 2025-06-02 | -2.21 |
| 2025-05-30 | -2.40 |
| 2025-05-29 | -2.26 |
| 2025-05-28 | -2.09 |
| 2025-05-27 | -2.18 |
| 2025-05-23 | -2.19 |
| 2025-05-22 | -2.20 |
| 2025-05-21 | -2.21 |
| 2025-05-20 | -2.36 |
| 2025-05-19 | -2.36 |
| 2025-05-16 | -2.42 |
| 2025-05-15 | -2.41 |
| 2025-05-14 | -2.30 |
| 2025-05-13 | -2.34 |
| 2025-05-12 | -2.60 |
| 2025-05-09 | -2.38 |
| 2025-05-08 | -2.57 |
| 2025-05-07 | -2.60 |
| 2025-05-06 | -2.43 |
| 2025-05-05 | -2.52 |